Explore Our Network

Explore MTEC's network of innovators, investors, and research organizations—along with patents and funding opportunities—advancing medical technologies for military and civilian health.

Showing 3 Patents
Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain

16-01-2018 • US-9867830-B2

WAINER, IRVING W. • MOADDEL, RUIN • BERNIER, MICHEL • ZARATE, CARLOS A. • TORJMAN, MARC C. • GOLDBERG, MICHAEL E. • TANGA, MARY J.

SRI International Inc • Cooper Health System Inc • Office of Technology Transfer

Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain

16-05-2017 • US-9650352-B2

WAINER, IRVING W. • MOADDEL, RUIN • BERNIER, MICHEL • ZARATE, CARLOS A. • TORJMAN, MARC C. • GOLDBERG, MICHAEL E. • TANGA, MARY J.

SRI International Inc • Cooper Health System Inc • US Department of Health and Human Services

Compounds for activating TGF-β signaling

17-01-2012 • US-8097645-B2

WYSS-CORAY, ANTON • TANGA, MARY J.

SRI International Inc • US Department of Veterans Affairs • Leland Stanford Junior University

Owner
Inventors
Assignee
Patent Type
Publication Year

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.